Tag: immune
Humans started to drink mammal’s milk 11,000 years ago. Nowadays, cow, goat and sheep milks account for about 87% of the world milk production.
4 days ago
 
The cosmetic use of devices like prostheses to increase breast volume is nothing new. I
18.03.2020
 
The assessment of skin fibrosis is vital for the diagnosis and monitoring of treatment in the systemic sclerosis (SSc)—a severe autoimmune disease.
18.03.2020
 
We read with interest the study published by Braaten and colleagues, analyzing the long-term outcomes of 60 patients developing persistent inflammatory arthritis (IA) after immune checkpoint inhibitors (ICIs) cessation.
27.01.2020
 
Immune checkpoint inhibitors (ICIs) are a new class of antineoplastic antibodies blocking inhibitory coreceptors on T cells. There are two classes of immune checkpoint receptor antibodies currently available, targeting either the cytotoxic T lymphocyte associated protein 4 (CTLA-4) or the programmed cell death 1 (PD-1) pathway.
22.01.2020
 
In Japan a significant number of adolescent girls complain of unusual symptoms after Human Papillomavirus (HPV) vaccination, and these symptoms, composed of orthostatic dysregulation, Chronic Regional Pain Syndrome (CRPS) and cognitive dysfunction are considered adverse effects of HPV vaccination.
26.10.2019
 
Immune checkpoint inhibitors block the checkpoint molecules. Different types of cancer immune checkpoint inhibitors have been approved recently: CTLA-4 monoclonal antibodies (as ipilimumab); anti-PD-1 monoclonal antibodies (as pembrolizumab and nivolumab); and anti-PD-L1 monoclonal antibodies (as atezolizumab, avelumab, and durmalumab).
16.07.2019
 
Cancer and autoimmune diseases are the two devastating conditions that together constitute a leading health problem worldwide. The rising burden of these disorders in the developing world demands a multifaceted approach to address the challenges it poses.
11.07.2019
 
Immune checkpoint inhibitors block the checkpoint molecules. Different types of cancer immune checkpoint inhibitors have been approved recently: CTLA-4 monoclonal antibodies (as ipilimumab); anti-PD-1 monoclonal antibodies (as pembrolizumab and nivolumab); and anti-PD-L1 monoclonal antibodies (as atezolizumab, avelumab, and durmalumab)
09.07.2019
 
Autoimmune polyendocrine syndrome type 2 (APS-2) is a polygenic disease in which HLA alleles and non-HLA genes determine the targeting of specific tissues by autoreactive T cells, leading to organ-specific autoimmunity.
25.06.2019